Update on influenza anti-virals

Respirology

Volumn 13, Issue SUPPL. 1, 2008, Pages

  Tambyah, Paul A ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antiviral treatment; Avian influenza; H5N1; Update

Indexed keywords

ADAMANTANE; AMANTADINE; OSELTAMIVIR; PERAMIVIR; PLACEBO; RIBAVIRIN; RIMANTADINE; ZANAMIVIR;

ANTIVIRAL SUSCEPTIBILITY; ANTIVIRAL THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS INFECTION; WORLD HEALTH ORGANIZATION;

ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; NEURAMINIDASE;

EID: 43349107623     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01249.x     Document Type: Conference Paper

References (20)

1. Chow A, Ma S, Ling AE, Chew SK. Influenza-associated deaths in tropical Singapore. Emerg. Infect. Dis. 2006 12 : 114 21.
2. Grant FW. The treatment of Influenza. Lancet 1895 ii : 638.
3. Barr IG, Hurt AC, Deed N, Iannello P, Tomasov C et al. The emergence of adamantane resistance in influenza A (H1) viruses in Australia and regionally in 2006. Antiviral Res. 2007 75 : 173 6.
4. Tumpey TM, García-Sastre A, Mikulasova A, Taubenberger JK, Swayne DE et al. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 2002 99 : 13849 54.
5. Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000 355 : 1845 50.
6. Lalezari J, Campion K, Keene O, Silagy C. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch. Intern. Med. 2001 161 : 212 7.
7. Tamiflu Information from Division Director Memorandum, Center for Drug Evaluation and Research, FDA, USA. [Accessed 2 Jan 2008.] Available from URL: http://www.fda.gov/cder/drug/infopage/tamiflu/directormemo.htm
8. Moscona A. Neuraminidase inhibitors for influenza. N. Engl. J. Med. 2005 353 : 1363 73.
9. Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob. Agents Chemother. 2001 : 45 : 2723 32.
10. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J. Antimicrob. Chemother. 2003 51 : 123 9.
11. The Writing Committee of the World Health Organization (WHO). Consultation on human influenza A/H5 avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 2005 353 : 1374 85.
12. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004 364 : 759 65.
13. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 2005 353 : 2667 72.
14. Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 2007 297 : 1435 42.
15. Evaluation of the Efficacy and Safety of Peramivir in Adults with Acute Serious or Potentially Life-Threatening Influenza. [Accessed 2 Jan 2008.] Available from URL: http://clinicaltrials.gov/show/NCT00453999
16. Ilyushina NA, Hoffmann E, Salomon R, Webster RG, Govorkova EA. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir. Ther. 2007 12 : 363 70.
17. Smee DF, Wong MH, Bailey KW, Sidwell RW. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses. Antivir. Chem. Chemother. 2006 17 : 185 92.
18. Schünemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM et al. WHO rapid advice guideline panel on avian influenza. WHO rapid advice guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect. Dis. 2007 7 : 21 31.
19. Lye DC, Nguyen DH, Giriputro S, Anekthananon T, Eraksoy H et al. Practical management of avian influenza in humans. Singapore Med. J. 2006 47 : 471 5.
20. Chen XY, Wu TX, Liu GJ, Wang Q, Zheng J et al. Chinese medicinal herbs for influenza. Cochrane Database Syst. Rev. 2005 1 : CD004559.